Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesStar Combo Pharma Ltd

Star Combo Pharma Ltd

Consumer Defensive Household & Personal Products
PortfolioPortfolio WatchlistWatchlist
Company price
0.14 AUD -0.04 ( 20.00%)
Last update at 2026-11-06T04:31:00Z
VOLUME
50393
Market Cap
18.91M

Momentum Score

…

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company engages in the development, manufacturing, marketing, and sale of natural health supplements and skin care products and provision of Chinese health products through its e-commerce platform. It sells its products under the Living Healthy, Costar, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.14
Low
0.17
High
52 Week Price Range
0.11
Low
0.27
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Publicly available information on Star Combo Pharma Ltd (S66.AU) is limited; the company is an Australia-listed entity that identifies as operating in the pharmaceutical/healthcare sector. Long-term growth may depend on successful product development, regulatory approvals and securing commercial partners, and investors may find exposure to potential upside from clinical or commercialization milestones appealing.
Key investment risks include limited disclosure and transparency, development and regulatory risk, potential funding and liquidity constraints, and competitive pressure in pharmaceutical markets, so investors should monitor cash position and milestone progress.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.17
Dividend Yield
1.76%
Revenue TTM
23.57M
Revenue Per Share
0.17
Gross Profit TTM
5.78M
Debt / Equity
0.11
ROE
1.02%
Net Debt
0.28M
ROCE
-0.53%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 0.53M 5.31M 1.00M -3.45M -1.08M
Net income 0.39M 5.25M 0.75M -4.00M -0.70M
Selling general administrative - 5.49M 5.08M 3.26M 3.90M
Selling and marketing expenses - 1.02M 0.68M 0.53M 0.64M
Gross profit 4.99M 6.27M 5.44M 7.16M 5.61M
Reconciled depreciation - - 1.59M 0.74M 0.78M
Ebit -0.23M 5.00M 1.20M 1.14M 0.55M
Ebitda 1.24M 6.64M 2.79M 1.88M 1.33M
Depreciation and amortization 1.47M 1.64M 1.59M 0.74M 0.78M
Operating income -0.23M -0.24M 0.72M 1.14M 0.55M
Other operating expenses 23.80M 28.05M 25.30M 23.87M 23.82M
Interest expense 0.20M 0.19M 0.20M 0.19M 0.17M
Tax provision - 0.06M 0.25M 0.55M -0.39M
Interest income - 0.12M 0.26M 0.23M 0.05M
Net interest income - - 0.07M -0.06M -0.12M
Income tax expense 0.13M 0.06M 0.25M 0.55M -0.39M
Total revenue 23.57M 27.81M 26.02M 24.70M 22.88M
Total operating expenses 5.22M 6.51M 4.72M 6.33M 6.55M
Cost of revenue 18.58M 21.54M 20.58M 17.54M 17.27M
Total other income expense net 0.76M 5.55M 0.28M -4.36M -1.63M
Net income from continuing ops - - 0.75M -4.00M -0.70M
Net income applicable to common shares - 5.25M 0.75M -4.00M -0.70M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 50.11M 48.45M 42.82M 42.23M 43.44M
Intangible assets 0.67M 0.67M - 0.69M 0.70M
Other current assets 0.40M 0.67M 0.17M 0.12M 0.14M
Total liab 11.28M 10.19M 9.30M 8.97M 8.04M
Total stockholder equity 38.83M 38.08M 33.32M 33.09M 35.41M
Other current liab 2.77M 1.72M 1.90M 1.73M 1.50M
Common stock 67.29M 67.29M 67.29M 67.29M 67.22M
Capital stock - - - 67.29M 67.22M
Retained earnings -30.80M -5.32M -35.57M -10.31M -7.06M
Other liab - - - 0.61M 0.08M
Good will - - - 0.00M 0.00M
Other assets - - - 0.71M 0.92M
Cash 3.91M 3.59M 2.16M 9.49M 10.39M
Cash and equivalents - - - 6.50M 6.00M
Total current liabilities 6.53M 5.86M 4.87M 4.33M 4.01M
Net debt 0.28M 0.34M 1.86M -5.30M -6.27M
Short term debt 0.30M 0.19M 0.16M 0.16M 0.17M
Short long term debt - - - 0.04M 0.04M
Short long term debt total 4.19M 3.93M 4.03M 4.19M 4.12M
Other stockholder equity - - - -23.89M -24.75M
Property plant equipment - - - 22.72M 22.74M
Total current assets 25.18M 25.79M 18.35M 18.10M 19.08M
Net tangible assets - - - 32.40M 34.71M
Short term investments 14.10M 14.52M 5.20M - -
Net receivables 3.35M 2.03M 4.48M 4.30M 3.18M
Long term debt - - - 0.01M 0.08M
Inventory 3.42M 4.97M 6.34M 4.20M 5.37M
Accounts payable 3.45M 3.95M 2.82M 2.44M 2.34M
Accumulated other comprehensive income 2.34M -23.89M 1.61M -23.89M -24.75M
Non currrent assets other - - 0.68M - -
Non current assets total 24.93M 22.66M 24.46M 24.12M 24.36M
Capital lease obligations - - - 4.15M 4.01M
Long term debt total - - - 4.03M 3.95M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - -0.14M -3.23M 4.05M
Change to liabilities - - - 1.02M 0.02M
Total cashflows from investing activities -2.02M -9.72M -0.14M -3.23M -3.24M
Net borrowings - - -0.04M 0.07M -0.17M
Total cash from financing activities -0.94M -0.80M -0.37M -0.05M -0.17M
Change to operating activities - - - 0.07M 0.05M
Net income 0.39M 5.25M 0.75M -4.00M -0.70M
Change in cash 0.32M 1.43M -0.82M -1.41M -2.88M
Begin period cash flow 3.59M 2.16M 2.99M 4.39M 7.27M
End period cash flow 3.91M 3.59M 2.16M 2.99M 4.39M
Total cash from operating activities 3.28M 11.94M -0.32M 1.88M 0.09M
Issuance of capital stock - - - 0.08M -
Depreciation 1.47M 1.90M 1.05M 0.70M 0.78M
Other cashflows from investing activities - -9.33M 1.30M -0.50M 4.05M
Dividends paid 0.50M -0.50M - - -
Change to inventory 1.55M 1.37M -2.14M 1.17M -0.87M
Change to account receivables -0.97M 2.10M -0.18M -1.15M -0.29M
Sale purchase of stock - - 0.00M 0.08M -
Other cashflows from financing activities -0.42M -0.20M -0.33M -0.06M -0.14M
Change to netincome - - - 4.06M 1.45M
Capital expenditures 2.45M 0.39M 1.44M 2.73M 7.29M
Change in working capital 1.32M 3.40M -2.11M 0.13M 0.54M
Other non cash items 0.08M 1.39M -0.00M - -0.09M
Free cash flow 0.82M 11.55M -1.76M -2.73M -7.21M

Peer Comparison*

Sector: Consumer Defensive Industry: Household & Personal Products

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
S66
Star Combo Pharma Ltd		 -0.04
20.00%		 0.14 - - 0.80 0.61 0.42 4.45
MCP
Mcphersons Ltd		 -
-%		 0.13 - 16.08 0.16 0.36 0.17 16.32
ZNO
ZOONO Group Ltd		 -0.00
5.00%		 0.04 - 8.88 9.73 5.76 11.89 -1.38
SKN
Skin Elements Ltd		 -
-%		 0.00 - - 30.26 8.04 27.95 -0.22
AN1
Anagenics Ltd		 0.00
20.00%		 0.01 - 4.97 0.95 1.17 1.14 7.77

Profile*

Star Combo Pharma Ltd

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company engages in the development, manufacturing, marketing, and sale of natural health supplements and skin care products and provision of Chinese health products through its e-commerce platform. It sells its products under the Living Healthy, Costar, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.

171-177 Woodpark Road, Smithfield, NSW, Australia, 2164

61 2 9756 6555

https://www.starcombo.com.au

Name Title Year Born
Ms. Su Zhang M.B.A. CEO & Exec. Director NA
Mr. JinXing Zhang B.S. Founder, MD & Director NA
Mr. James Ni Chief Financial Officer NA
Mr. He Ben B.S. Chief Operating Officer NA
Mr. Patrick James Raper F.A.C.I.D., FAICD, FCPA Company Sec. NA
Ms. Su Zhang M.B.A. CEO & Executive Director NA
Ms. Su Zhang M.B.A. CEO & Executive Director NA
Mr. Patrick James Raper F.A.C.I.D., FAICD, FCPA Company Secretary NA
Ms. Su Zhang M.B.A. CEO & Executive Director NA
Mr. Patrick James Raper F.A.C.I.D., FAICD, FCPA Company Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…